ATE73659T1 - Verwendung von cobalt proto-und mesoporphyrin zur herstellungeines arzneimittels zur hemmung des endocrinen systems. - Google Patents
Verwendung von cobalt proto-und mesoporphyrin zur herstellungeines arzneimittels zur hemmung des endocrinen systems.Info
- Publication number
- ATE73659T1 ATE73659T1 AT87900460T AT87900460T ATE73659T1 AT E73659 T1 ATE73659 T1 AT E73659T1 AT 87900460 T AT87900460 T AT 87900460T AT 87900460 T AT87900460 T AT 87900460T AT E73659 T1 ATE73659 T1 AT E73659T1
- Authority
- AT
- Austria
- Prior art keywords
- mesoporphyrin
- proto
- cobalt
- inhibiting
- drug
- Prior art date
Links
- NCAJWYASAWUEBY-UHFFFAOYSA-N 3-[20-(2-carboxyethyl)-9,14-diethyl-5,10,15,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1(21),2,4,6(24),7,9,11,13,15,17,19-undecaen-4-yl]propanoic acid Chemical compound N1C2=C(C)C(CC)=C1C=C(N1)C(C)=C(CC)C1=CC(C(C)=C1CCC(O)=O)=NC1=CC(C(CCC(O)=O)=C1C)=NC1=C2 NCAJWYASAWUEBY-UHFFFAOYSA-N 0.000 title 1
- 229910017052 cobalt Inorganic materials 0.000 title 1
- 239000010941 cobalt Substances 0.000 title 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 230000002124 endocrine Effects 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 210000000750 endocrine system Anatomy 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Vehicle Body Suspensions (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Studio Devices (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83251286A | 1986-02-21 | 1986-02-21 | |
| US92783086A | 1986-11-06 | 1986-11-06 | |
| PCT/US1986/002600 WO1987004927A1 (en) | 1986-02-21 | 1986-12-03 | Methods for suppressing the endocrine system |
| EP87900460A EP0259353B1 (de) | 1986-02-21 | 1986-12-03 | Verwendung von Cobalt proto-und mesoporphyrin zur Herstellungeines Arzneimittels zur Hemmung des endocrinen Systems. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE73659T1 true ATE73659T1 (de) | 1992-04-15 |
Family
ID=27125543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87900460T ATE73659T1 (de) | 1986-02-21 | 1986-12-03 | Verwendung von cobalt proto-und mesoporphyrin zur herstellungeines arzneimittels zur hemmung des endocrinen systems. |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0259353B1 (de) |
| AT (1) | ATE73659T1 (de) |
| AU (2) | AU6839687A (de) |
| DE (1) | DE3684474D1 (de) |
| WO (1) | WO1987004927A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4997828A (en) * | 1989-02-14 | 1991-03-05 | The Rockefeller University | Method of weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin |
| US5192757A (en) * | 1990-12-20 | 1993-03-09 | Glaxo Inc. | Cobalt porphyrins |
| US5149697A (en) * | 1991-04-18 | 1992-09-22 | Glaxo Inc. | Cobalt porphyrin pharmaceutical compositions |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4393071A (en) * | 1975-03-17 | 1983-07-12 | Naoharu Fujii | Method of treating gastric, mammary, lung and uterus tumors |
-
1986
- 1986-12-03 AT AT87900460T patent/ATE73659T1/de not_active IP Right Cessation
- 1986-12-03 AU AU68396/87A patent/AU6839687A/en not_active Withdrawn
- 1986-12-03 WO PCT/US1986/002600 patent/WO1987004927A1/en not_active Ceased
- 1986-12-03 EP EP87900460A patent/EP0259353B1/de not_active Expired
- 1986-12-03 DE DE8787900460T patent/DE3684474D1/de not_active Expired - Lifetime
-
1988
- 1988-01-15 AU AU10333/88A patent/AU598898B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP0259353B1 (de) | 1992-03-18 |
| WO1987004927A1 (en) | 1987-08-27 |
| AU598898B2 (en) | 1990-07-05 |
| DE3684474D1 (de) | 1992-04-23 |
| AU1033388A (en) | 1988-05-05 |
| EP0259353A4 (de) | 1990-02-05 |
| EP0259353A1 (de) | 1988-03-16 |
| AU6839687A (en) | 1987-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3035730T3 (en) | Inhibitors of dipeptidyl-aminopeptidase type iv. | |
| DE3885253D1 (de) | Harzsysteme für beschichtete Produkte und Methode. | |
| DK0654078T3 (da) | Thrombinblodfraktion til anvendelse i en medicinsk procedure | |
| DE68908439D1 (de) | Quatenaere-ammonium-verbindungen zur verwendung in bleich-systemen. | |
| DE68924888D1 (de) | System zur Überwachung von Personen. | |
| NO971568D0 (no) | Analoger av keratinocyttvekstfaktor | |
| DE68917037D1 (de) | System zur Stromversorgung. | |
| FI964253A0 (fi) | Kollageenivalmiste vaikuttavien aineiden säädellyksi vapauttamiseksi | |
| ATE149523T1 (de) | Verfahren zur herstellung von interferon-alpha-2 kristallen | |
| DE3676601D1 (de) | Mittel zur injektion von aktiviertem vitamin-d3. | |
| DE58901151D1 (de) | Verfahren zur herstellung von katalysatoren und ihre verwendung zur herstellung von isocyanuratgruppen aufweisenden polyisocyanaten. | |
| DE3888422D1 (de) | Kultursystem und Behälter zur Verwendung in diesem System. | |
| DE3788796D1 (de) | Serumfreies medium zur proliferation von lymphokin-aktivierten töterzellen. | |
| ATE73659T1 (de) | Verwendung von cobalt proto-und mesoporphyrin zur herstellungeines arzneimittels zur hemmung des endocrinen systems. | |
| DE69535263D1 (de) | Angiotensin ii zur verbesserung der befruchtung | |
| DE3778158D1 (de) | Inhibitoren von esterase produzierenden mikroorganismen zur hauptverwendung in deodorants. | |
| DE59100964D1 (de) | Verwendung von Zink-Calciumhydroxid, Lecithin und PAO zur Adjuvierung von Antigenlösungen und auf diese Weise adjuvierte Antigenlösungen. | |
| AU3016089A (en) | Inhibitors of lysyloxidase | |
| NO174691C (no) | Anvendelse av 1-hydroksymetylpyrazoler for kontroll av mikroorganisasjoner i vandige systemer | |
| DE69428909D1 (de) | Für die immun- und cns-therapie nutzbare, neuartige tripeptide | |
| DE3881538D1 (de) | Verwendung eines klebstoffes zur palettisierung. | |
| ES8707706A1 (es) | Un procedimiento para la preparacion de nuevos derivados de propanodiona. | |
| DE3670947D1 (de) | Mittel zur regulierung des pflanzenwachstums. | |
| IT8820916A0 (it) | Procedimento ed impianto per la coltura di microorganismi. | |
| ATE49964T1 (de) | Benzodioxepane, verfahren zur herstellung und verwendung als heilmittel. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |